发明名称 Treating post-seizure patients
摘要 Patients are subject to a post-seizure treatment regime to separately inhibitor consecutive targets of an epileptogenic cascade comprising neurotransmitter receptor signaling, kinase/phosphatase activity, protein translation, and apoptosis or inflammation.
申请公布号 US8785446(B2) 申请公布日期 2014.07.22
申请号 US201012688892 申请日期 2010.01.17
申请人 Children's Medical Center Corporation 发明人 Jensen Frances E.;Rakhade Sanjay N.
分类号 A61K31/47;A61K31/498;A61K31/18;A61K31/366 主分类号 A61K31/47
代理机构 Fish & Richardson P.C. 代理人 Fish & Richardson P.C.
主权项 1. A therapeutic method for treating a patient post-seizure comprising administering to the patient NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione), KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine), and rapamycin.
地址 Boston MA US